COVID-19 in the Critically Ill: Too Risky for High-Dose Anticoagulation?

Paez Vargas, Juan José; Vidal González, Anxela; Pérez-Calvo, César; Flandes, Javier

Paez Vargas, Juan José; Vidal González, Anxela; Pérez-Calvo, César; Flandes, Javier.

Paez Vargas JJ; Intensive Care Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain. Electronic address: jjpaezv@icloud.com.
Vidal González A; Intensive Care Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Pérez-Calvo C; Intensive Care Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.
Flandes J; Interventional Pulmonology Department, Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain.

Chest ; 160(2): e249, 2021 08.

Article in English | MEDLINE | ID: covidwho-1333291

Subject(s)

COVID-19; Critical Illness; Anticoagulants/adverse effects; Blood Coagulation; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Critical Illness / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Chest Year: 2021 Document Type: Article

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google